Skip to main content
. 2016 Jun 7;7(27):41285–41293. doi: 10.18632/oncotarget.9778

Figure 2. Prognostic value of the AR in TNBC patients was improved by combining BRCA1 status.

Figure 2

a. Cumulative Disease-free Survival(DFS) curves of TNBC patients by BRCA1 status. b. Kaplan-Meier estimates of DFS according to AR and BRCA1 statuses in TNBC patients (log rank P = 0.062) c. ROC curves assessing the distinct performances of the combined and the traditional models for predicting the DFS in the TNBC cohort. Variables for the traditional model include TNM stage only. AR and BRCA1 were added in the combined model. p < 0.001 for AUC comparison.